コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 late trapped in a layer of mucous out of the upper airway.
2 ates the mucosal innate defense of the human upper airway.
3 ole in the overall respiratory health of the upper airway.
4 aryngeal movements to achieve closure of the upper airway.
5 ding on the underlying collapsibility of the upper airway.
6 l and pathogenic bacteria that reside in the upper airway.
7 tment of these muscles as stabilizers of the upper airway.
8 s on identifying sites of obstruction in the upper airway.
9 iameter (D) in sleeping humans with narrowed upper airways.
10 ng its potential niche as a commensal of the upper airways.
11 viral subtypes is likely to occur in ferret upper airways.
12 lococcus aureus, a frequent colonizer of the upper airways.
13 respiratory tract that is used to clear the upper airways.
14 ns that are expressed in the oral cavity and upper airways.
15 ns that are expressed in the mouth, nose and upper airways.
16 des of the skin, gastrointestinal tract, and upper airways.
17 preceded by asymptomatic colonization of the upper airways.
18 involvement beyond mere colonization of the upper airways.
19 lty swallowing, indicating impairment of the upper airways.
20 disturbances, particularly the impairment of upper airways.
21 lty swallowing, suggesting impairment of the upper airways.
22 he presented with cardiac arrest, ice in her upper airways, a first-documented nasopharyngeal tempera
23 lecule probes to the epithelial cells of the upper airways, a multiscale computational model of the l
30 ow OA alters AHI and four phenotypic traits (upper-airway anatomy/collapsibility and muscle function,
31 < 0.05), which was driven by improvements in upper-airway anatomy/collapsibility under passive (1.9 +
34 t target for modulating the fluid content of upper airway and nasopharyngeal secretions in disorders
36 ogen, is naturally capable of colonizing the upper airway and sometimes disseminating to remote tissu
40 e characterized by local inflammation of the upper airways and sinuses and is frequently divided into
42 ubmucosal glands supply most of the mucus in upper airways, and gland serous cells are the primary si
43 y small volume (<1 mL) is instilled into the upper airways, and with programmed air ventilation of th
46 their role in bacterial colonization of the upper airway as well as how viruses might contribute to
47 ureus, an organism frequently colonizing the upper airways, at the human mucosal site of the disease.
50 relationships of the tissues surrounding the upper airway (bone and soft tissues) in 92 normal childr
53 Nested case-control analyses of 115 men with upper airway cancer (including 1 nasopharyngeal cancer),
54 nd and Wales, and associations with incident upper airway cancer and leukemia were explored in nested
57 an increasingly common disorder of repeated upper airway collapse during sleep, leading to oxygen de
61 iveness to negative epiglottic pressure, and upper airway collapsibility during passive and active co
64 sing multivariate analysis, baseline passive upper-airway collapsibility and loop gain were independe
65 indings suggest that OA therapy improves the upper-airway collapsibility under passive and active con
66 philus influenzae (NTHi) are closely related upper airway commensal bacteria that are difficult to di
68 thma, gastro-oesophageal reflux disease, and upper airway conditions, and that it can be cured in mos
72 sized that respiratory cycle fluctuations in upper airway cross-sectional area would be larger in chi
73 ompared with control subjects: (1) a smaller upper airway cross-sectional area, particularly during i
74 (1) upper airway anatomy, (2) the ability of upper airway dilator muscles to respond to rising intrap
79 This group with so-called severe chronic upper airway disease (SCUAD) represents a therapeutic ch
80 ars to be related to the presence of lung or upper airway disease and anti-PR3 antibody seropositivit
85 of the available literature on occupational upper airway disease with a focus on pathophysiological
90 ce interval) than controls for incidence of: upper airway diseases, including adenotonsillitis (3.29,
92 importance to increase the awareness towards upper airway disorders in the swimming athletes and to e
94 lerance, we isolated CD4(+) T cells from the upper airway draining lymph nodes of both OVA323-339- an
97 a due to a rapid increase in pressure in the upper airways during sneezing, coughing, or vomiting, wh
99 per airway patency, such that measurement of upper airway dynamics using acoustic pharyngometry may c
100 uently, in aging Tau-P301L mice, progressive upper airway dysfunction is linked to progressive tauopa
101 Because patients with tauopathy suffer from upper airway dysfunction, the Tau-P301L mice can serve a
102 ysfunction syndrome (RADS), asthma, reactive upper airways dysfunction syndrome (RUDS), gastroesophag
104 egrins accumulate on the luminal membrane of upper-airway epithelial cells from mice and humans with
105 ted over time, we demonstrate that the human upper airway epithelium is maintained by an equipotent b
106 ins and toxins that mediate adherence to the upper airway epithelium, an essential early step in path
107 tensity and the pressure gradient across the upper airway (estimated with oesophageal pressure, Pes)
108 To summarize the current state of the art in upper-airway evaluation, focusing on endoscopic techniqu
109 we review the emerging inflammatory roles of upper airway fibroblasts, the majority of which appear t
110 sts were susceptible to RSV infection of the upper airway following intranasal challenge; however, th
111 se data suggest that the middle-aged men had upper airway function midway between that of young norma
112 rons, which control tongue muscles affecting upper airway function, that is metamodulated by metabotr
116 to drop to nearly zero on exhalation; in the upper airways gamma is approximately 30 mN/m and constan
118 ws dynamic estimation of changes in relative upper airway hydraulic diameter (D) in sleeping humans w
119 n treatment during RSV bronchiolitis reduced upper airway IL-8 levels, prolonged the time to the thir
120 and automatic segmentation to delineate the upper airway in 20 children with obstructive sleep apnea
121 to negative pressure applied to the isolated upper airway in anaesthetized rats before and after micr
122 lung volume have an important effect on the upper airway in subjects with sleep apnea during non-REM
125 thalmological examination (recent history of upper airway infections and/or head and neck surgeries a
127 weeks of age due to overwhelming suppurative upper airway infections that were associated with neutro
130 f the current state of the art of control in upper airway inflammation and stressing the unmet needs
131 sponsible for the lack of control in chronic upper airway inflammation are often but not always linke
135 chanisms that cause persistent, exaggerated, upper airway inflammation rather than acute resolving il
137 was to identify potential differences in the upper airways inflammatory response after exposure to LM
138 respiratory distress syndrome as well as in upper-airway inflammatory diseases, such as chronic obst
142 f the soft tissue structures surrounding the upper airway is enlarged in patients with sleep apnea an
143 Segmental analysis demonstrated that the upper airway is restricted throughout the initial two-th
144 bacterial colonization (or carriage) in the upper airway is the prerequisite of all these infections
146 a chronic inflammatory disease affecting the upper airways, is a valuable and accessible model to inv
147 assortant viruses from tissues of the ferret upper airway, it is reasonable to conclude that continue
148 by recurrent episodes of obstruction of the upper airway leading to sleep fragmentation and intermit
150 s varies; predisposing factors include small upper airway lumen, unstable respiratory control, low ar
151 recruitment of monocyte/macrophages into the upper airway lumen, where they engulfed pneumococci.
152 unds generated by different vibrators of the upper airway may be useful indicators of obstruction sit
154 previously found that children with smaller upper airways (measured by magnetic resonance imaging wh
155 rging evidence indicates associations of the upper-airway microbiome with bronchiolitis severity, lit
156 nt hypoxia may result in oxidative injury to upper airway motoneurons, thereby diminishing serotonerg
158 m nuclei, directly or indirectly involved in upper airway motor control (i.e., the Kolliker-Fuse, per
161 help in the development of therapeutics for upper airway motor disorders such as obstructive sleep a
162 TSLP-responding DC populations in the human upper airway mucosa and assess the TSLP-mediated effects
163 well as in the inflammatory response of the upper airway mucosa and in wound healing, presumably thr
164 nting on the cytokines and chemokines in the upper airway mucosal lining fluid of healthy neonates.
165 plasticity of XII motor output may increase upper airway muscle (innervated by XII nerve) tone and i
166 minantly theta EEG activity) on ventilation, upper airway muscle activation and upper airway resistan
169 ts that the initial sleep onset reduction in upper airway muscle activity is due to loss of a 'wakefu
170 st that the initial sleep onset reduction in upper airway muscle activity is due to loss of a 'wakefu
171 geal anatomy/collapsibility, loop gain (LG), upper-airway muscle responsiveness (gain) and the arousa
172 without apnea exhibited a threefold greater upper-airway muscle responsiveness than both overweight/
173 ssociated with the recruitment of four major upper airway muscles (genioglossus, digastric, sternohyo
176 per subject, after the local anatomy of the upper airway musculature was examined by ultrasonography
178 Healthy children have wide variation in upper airway neuromuscular compensatory responses and ar
183 ntify clinically significant post-extubation upper airway obstruction (UAO) and differentiate subglot
185 re measurements correlate with the degree of upper airway obstruction during sleep and may have a rol
187 t in many neuromuscular disorders mechanical upper airway obstruction from oropharyngeal weakness con
190 latory pressures, pulmonary dysfunction, and upper airway obstruction that occur after combined smoke
192 longer length of ventilation, postextubation upper airway obstruction, high respiratory effort postex
193 ologic disease, lower aPiMax, postextubation upper airway obstruction, higher preextubation positive
197 tory laryngeal adduction with closure of the upper airway occurs and likely functions to aid autoresu
198 mal sensory responses have been found in the upper airway of obstructive sleep apnea patients, but no
205 recruitment of ILC2s and granulocytes to the upper airways of subjects with atopy and healthy subject
206 As a consequence, samples taken from the upper airway often captured only a fraction of the popul
207 tromyograms, videofluoroscopic images of the upper airway, oronasal airflow and respiratory inductanc
209 pontine Kolliker-Fuse nucleus (KF) controls upper airway patency and regulates respiration, in parti
210 ctive of this study was to determine whether upper airway patency can be improved using chemogenetic
214 rength than the diaphragm, and impairment of upper airway patency is a key mechanism of extubation fa
215 which plays an important role in maintaining upper airway patency, particularly during sleep, and mod
216 akefulness, active neural processes preserve upper airway patency, such that measurement of upper air
219 ic (passive critical closing pressure of the upper airway [Pcrit]) and nonanatomic (genioglossus musc
220 y contrast, the number of swallows evoked by upper airway/pharyngeal distensions was not significantl
221 ous studies suggested an association between upper airway pneumococcal colonization density and pneum
222 mproved adaptation of A(H7N9) virus to human upper airway poses an important threat to public health.
224 ogical colonization owing to the efficacy of upper airway-protective mechanisms and the host mucosal
225 ies lead to primary ciliary dyskinesia, with upper-airways recurrent infections, left-right asymmetry
226 ) were evaluated as markers of activation of upper airway remodeling using image analysis, together w
228 848 were used to mimic a viral insult in the upper airways represented by primary human nasal epithel
230 designed to assess whether elevated sleeping upper airway resistance (R(UA)) alters the ventilatory r
231 estigated muscle activity, ventilation , and upper airway resistance (UAR) during wakefulness and sle
232 tilation, upper airway muscle activation and upper airway resistance (UAR) in middle-aged and younger
237 show that serotonin-dependent plasticity in upper airway respiratory output is similar in F344 and S
240 thanol-fed rats in vivo with rGM-CSF via the upper airway restored GM-CSF receptor membrane expressio
242 udied whole-genome deep sequencing of RSV in upper airway samples from an infant with severe combined
244 ctive sleep apnea syndrome involves abnormal upper airway sensory input, which may be responsible for
246 <0.01), 19% had a relatively noncollapsible upper airway similar to many of the control subjects (Pc
247 at lung volume during wakefulness influences upper airway size and resistance, particularly in patien
249 geted branches of the pulmonary airway tree: upper airways, small airways (bronchioles), or the most
251 than control subjects; (3) the size of other upper airway soft tissue structures (volume of the tongu
252 first time family aggregation of size of the upper airway soft tissue structures has been demonstrate
253 maging in a case-control design to study the upper airway soft tissue structures in 48 control subjec
254 , our data indicate that heritability of the upper airway soft tissue structures is found in normal s
256 study the family aggregation of the size of upper airway soft tissue structures that are associated
257 phoid tissue, rather than enlargement of the upper airway soft tissue structures, is the primary anat
262 od-like receptor-stimulating bacteria in the upper airway (Staphylococcus aureus and Staphylococcus e
264 ted the clinical safety and effectiveness of upper-airway stimulation at 12 months for the treatment
265 p, cohort design, we surgically implanted an upper-airway stimulation device in patients with obstruc
267 without apnea have a moderately compromised upper-airway structure that is mitigated by highly respo
268 nfectious and non-infectious diseases of the upper airways, such as otitis media, adenotonsillitis, r
269 ade to achieve intubation success, including upper airway suctioning (used in 43% of attempts resulti
273 ects with atopy displayed rapid induction of upper airway symptoms, an enrichment of ILC2s, eosinophi
274 1, asthma with a moderate course, intensive upper airway symptoms, and blood eosinophilia (18.9% of
275 n, their less efficient replication at human upper airway temperatures has implications for the under
276 itis (CRS) is an inflammatory disease of the upper airways that affects 10% of Europeans and American
278 smoke have been placed on the lungs and the upper airways, this finding highlights the fact that mul
282 low transducer were placed in the lung model upper airway to measure the volume of CO2 rebreathed and
283 throughout the airways usually occur in the upper airways, tonsils, and adenoid structures that make
286 and obese rats was associated with decreased upper airway (UA) collapsibility (p < 0.05), unchanged m
287 at RAGE protein is highly expressed in human upper airways under normal physiology and that it is sub
290 ruction by evaluating dynamic changes in the upper airway using drug-induced sleep computed tomograph
293 Fiberoptic imaging in an isolated, sealed upper airway was performed in 10 decerebrate cats to det
294 st-inspiratory drive (adductor motor) to the upper airways was enhanced in amplitude and duration in
296 eeks genioglossus EMG and dynamic MRI of the upper airway were performed before and after administrat
297 ve apnea patients have an anatomically small upper airway with augmented pharyngeal dilator muscle ac
298 pothesized that reducing inflammation in the upper airway with intranasal corticosteroid (INCS) medic
299 y is due to an anatomically more collapsible upper airway with more negative pressure driven muscle a
300 tis (CRS) is a multifactorial disease of the upper airways with a high prevalence (approximately 11%)
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。